Skip to main content

Table 1 Comparison of clinical variables between non-cachexia and cachexia patients

From: Plasma concentration of interleukin-6 was upregulated in cancer cachexia patients and was positively correlated with plasma free fatty acid in female patients

 

Non-cachexia (n = 237)

Cachexia (n = 74)

t/x2

p

Ages (years)

62.34 ± 0.73

64.14 ± 1.19

1.226

0.221

Female no. (%)

87 (36.7%)

24 (32.4%)

0.449

0.503

BMI (kg/m2)

22.91 ± 0.19

22.08 ± 0.38

2.036

0.043

HB (g/L)

119.5 ± 1.68

111.8 ± 3.02

2.227

0.027

WBC (10^9/L)

5.72 ± 0.11

6.07 ± 0.25

1.422

0.156

PLT (10^9/L)

237.9 ± 5.15

262.9 ± 11.75

2.211

0.028

LY (10^9/L)

1.64 ± 0.04

1.40 ± 0.05

3.168

0.002

TP (g/L)

65.36 ± 0.41

63.64 ± 0.78

2.016

0.045

ALB (g/L)

40.88 ± 0.32

39.15 ± 0.56

2.675

0.008

PA (g/L)

0.214 ± 0.004

0.189 ± 0.006

3.525

<0.001

TC (mmol/L)

4.19 ± 0.07

3.91 ± 0.09

2.149

0.033

TG (mmol/L)

1.32 ± 0.04

1.17 ± 0.06

1.902

0.058

ApoA (g/l)

176.8 ± 12.62

220.1 ± 23.61

1.677

0.095

ApoB (g/l)

0.873 ± 0.017

0.852 ± 0.029

0.604

0.547

ApoE (g/l)

41.55 ± 0.82

36.78 ± 1.36

2.919

0.004

FFA (pg/ml)

0.42 ± 0.02

0.48 ± 0.03

2.022

0.044

IL-6 (pg/ml)

4.88 ± 0.28

8.16 ± 0.98

4.429

<0.001

TNF-α (pg/ml)

7.45 ± 0.23

8.09 ± 0.37

1.398

0.164

(I + II) TNM stage no. (%)

125 (52.7%)

24 (32.4%)

9.321

0.002

  1. BMI Body mass index, HB Hemoglobin, WBC White blood cell count, PLT Platelet, LY Lymphocyte count, TP Total protein, ALB Albumin, PA Prealbumin, TC Total cholesterol, TG Tri-glyceride, ApoA Apolipoprotein A, ApoB Apolipoprotein B, ApoE Apolipoprotein E, FFA Free fatty acid